Facts and News
Financial highlights
1,663,016
BGN '000 Revenues 2022
139,980
BGN '000 EBITDA 2022
Stock performance
Bulgarian Stock Exchange
Warsaw Stock Exchange
Corporate News
28 October 2021
![](https://www.sopharmagroup.com/sites/sopharma2016corp/files/styles/home_press_image/public/ognyan_donev_vietnam_visit_0.jpg?itok=m9kMgDfQ)
![](https://www.sopharmagroup.com/sites/sopharma2016corp/files/styles/home_press_image/public/default_images/generica2.png?itok=WwIuHCD4)
![](https://www.sopharmagroup.com/sites/sopharma2016corp/files/styles/home_press_image/public/default_images/generica2.png?itok=WwIuHCD4)
Stories